193359-84-1

Upstream product

• 617-04-9 (2R,3S,4S,5S,6S)-2-(hydroxymethyl)-6-methoxytetrahydro-2H-pyran-3,4,5-triol 
• 193359-82-9 (3aS,4S,6R,7R,7aS)-6-(2-Azido-ethoxymethyl)-4,7-dimethoxy-2,2-dimethyl-tetrahydro-[1,3]dioxolo[4,5-c]pyran 
• 131089-34-4 3-O-benzoyl-6-O-(t-butyldiphenyl)silyl-α-D-mannopyranoside 
• 131089-36-6 methyl 6-O-tert-butyldiphenylsilyl 2,3-O-isopropylidene-4-O-methyl-α-D-mannopyranoside 
• 131089-35-5 methyl 6-O-tert-butyldiphenylsilyl-2,3-O-isopropylidene-α-D-mannopyranoside 
• 82185-76-0 methyl 2,3-O-isopropylidene-4-O-methyl-α-D-mannopyranoside 
• 100-39-0 benzyl bromide 
• 193359-83-0 (2S,3S,4R,5S,6R)-6-(2-Azido-ethoxymethyl)-2,5-dimethoxy-tetrahydro-pyran-3,4-diol 

Relevant academic research and scientific papers

Design, synthesis and biological evaluation of carbohydrate-based mimetics of cRGDFV

The design, synthesis and preliminary biological evaluation of carbohydrate-based non-peptide mimetics of the potent peptidic antagonist of α(v)β3 and α(v)β5, pentapeptide cRGDFV (1) is presented. The design was based on the NMR-determined structure of 1.